The 8th ADVANCES AGAINST ASPERGILLOSIS will take place in Lisbon, Portugal, on 1-3 February 2018 This conference has now established itself as the premier forum for detailed and dedicated discussion of all aspects of Aspergillus infection and research and provides an opportunity for the world’s aspergillosis experts to gather in one venue. The latest advances and thoughts […]
Clinical Trials Centre Cologne (CTCC) manages the study conduct in Europe; University Hospital of Cologne as ECMM Excellence Centre offers a perfect platform for research in fungal diseases. Fungal diseases are on the rise. Over 1 billion patients are affected and 25 million people are at imminent risk of severe organ damage or death due […]
New paper focusing on “Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases” published Open Access in Mycoses under http://onlinelibrary.wiley.com/doi/10.1111/myc.12727/full, by Martin Hoenigl, FECMM and colleagues.
The Medical Mycology Course 2018 will take place at the Institut Pasteur – Paris form 5th -30th March 2018. Target audience are Microbiologists (MDs, PhDs & veterinarians) with previous practice in medical mycology lab (> 1 year experience). Among the lecturers are a number of Fellows of the ECMM (S. Bretagne, J.P. Gangneux, F. Lanternier, […]
The Global Alliance for Infections in Surgery published “A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway” endorsing antimicrobial stewardship. The full publication in different languages can be found here http://online.liebertpub.com/doi/pdfplus/10.1089/sur.2017.219
This ASM ESCMID conference on drug development to meet the emerging resistance is the 3rd joint effort to bring people together moving the field of drug development forward. Antifungals are off course also on the list so the conference would be in the interest of ECMM members, particularly taken into consideration the emerging echinocandin and […]